09:06 AM EDT, 04/10/2024 (MT Newswires) -- Treatment.com AI Inc. ( TREIF ) , which gained 9.5% yesterday, on Wednesday signed a collaborative agreement with aiXplain, Inc. to enable greater access to Treatment's Global Library of Medicine (GLM) by contributing to aiXplain's Artificial Intelligence (AI) marketplace.

According to a statement, the GLM has been developed over the past seven years, in collaboration with hundreds of healthcare professionals globally, utilizing proprietary algorithms. aiXplain's marketplace makes it possible for healthcare organizations to access Treatment's AI engine through its development framework and enhance the quality of clinical diagnosis within their organizations across multiple platforms, the statement said.

Treatment and aiXplain also intend to explore mutually beneficial international opportunities through the partnership. Both parties have a shared interest in the future to provide the GLM in multiple languages.

The collaboration also allows aiXplain and Treatment to collaborate on testing and development of new mutual joint commercial applications and/or solutions.

Dr. Essam Hamza, CEO of Treatment.com AI ( TREIF ), said, "It helps fulfill our shared philosophies in the democratization of AI. Our goal is to have Treatment's Global Library of Medicine (GLM) AI accessible to healthcare organizations and healthcare professionals alike, and aiXplain's marketplace creates new opportunities for all parties."